Subscribe to Search results

The result of the FDA meeting was reported by Dr Fowler in a memo. He noted that the possibility of banning all products made before the implementation of the March 1983 regulations was rejected.

Published on:

Dr Fowler argued that the 13 July 1983 CSM(B) recommendation implied that 'pre-March 83' material should be used until adequate supplies of 'post-March 83' material were available.

Published on:

In a memo to Dr Walford, Dr Fowler expressed concerns that US manufacturers "may try to dump blood products produced from plasma collected prior to the March 1983 FDA regulations on the UK market."

Published on:

In a letter Ken Milne (Haemophilia Society) stated that the Haemophilia Society should place less emphasis on NHS concentrate and plans for self-sufficiency.

Published on:

Dr Kernoff responded to the statement that American people with haemophilia who had been treated with commercial Factor 8 concentrates had low T4/T8 ratios by saying "haemophiliacs who had been treated with cryoprecipitate usually had normal ratios. None of the patients with low ratios had AIDS".

Published on:

The Morbidity and Mortality Weekly Report reported that there was highly likely to be a viral cause of AIDS, transmissible by sex.

Published on:

In a letter, Reverend Tanner asked Professor Bloom to attend the next Haemophilia Society meeting, at which the main subject would be a discussion about AIDS.

Published on:

In a letter, Dr Galbraith (Communicable Disease Surveillance Centre) raised concerns about the risk of AIDS from blood products from the US.

Published on:

In a journal article by Dr Lee and others it was reported that there was a correlation between receiving imported Factor 8 concentrate and having low T4/T8 ratios.

Published on:

In a letter, Professor Bloom stated there had not been any major change with the status of AIDS in the UK and did not think the recommendations of the World Federation of Haemophilia Medical Board should be circulated to Haemophilia Society members.

Published on:

In a letter to Reverend Tanner (Haemophilia Society), Professor Bloom informed him that there had been little further development on AIDS.

Published on:

Following an article in the Mail on Sunday titled "Hospitals using killer blood", Professor Bloom provided a draft note for circulation to the members of the Haemophilia Society concerning the AIDS situation.

Published on:

An update on AIDS was published in Haemofact on AIDS Release No. 3 by Dr Lee, which stated: "In Great Britain the number of haemophiliacs who have been reported with AIDS remain at 2. Thus the incidence is less than 1 in 1,000 patients at risk."

Published on:

Haemofact on AIDS Release No. 7 was published by the Haemophilia Society which provided information about safe sex.

Published on:

In a meeting of the Medical Research Council Working Party on AIDS, it was reported that the wife of a person with haemophilia had developed AIDS.

Published on:

In a meeting between the Department of Health and Social Security and the Haemophilia Society, there was no discussion of the view that hepatitis was a serious disease with significant long-term consequences.

Published on:

David Watters was recorded as having phoned the Department of Health to say that having consulted with the Haemophilia Society's lawyers the sum of £86 million would be required to bring legal action to an end.

Published on:

An article titled "Panic and the blood" was published in The Guardian, which criticised Norman Fowler's decision to depend largely on American Factor 8 imports rather than buying from countries where AIDS was not prevalent or seeking to become self-sufficient.

Published on:

Reverend Tanner and David Watters (together with the Society's adviser on parliamentary lobbying) met Strachan Heppell, a senior civil servant. They were recorded as expressing the Society's interest in achieving an out-of-court settlement for compensation.

Published on:

In a letter to Richard Gutowski, Karin Pappenheim noted that the Skipton Fund made no provision for those who had died, or those who had cleared the virus through treatment, and that by opting for cirrhosis as a trigger for higher payments it missed out many suffering significantly from serious advanced liver disease or liver damage.

Published on: